May prior Chlamydia pneumoniae infection may determine the development of chronic inflamation in obesity?
Monika Koziołek, Barbara Krzyżanowska-Świniarska, Tomasz Miazgowski, Krystyna Pilarska
Endokrynol. Otył. Zab. Przem. Mat 2006;2(4):129-133.
open access
Vol 2, No 4 (2006)
Prace poglądowe
Published online: 2007-01-25
Abstract
Obesity is associated with a mild and chronic inflammatory process.
There is increasing evidence that in obesity the adipocytes
secrete numerous bioactive substances, such as CRP,
IL-6, TNF-α, leptin and adiponectin. Thus, adipose tissue actively
contributes in the development of inflammatory response.
Among many theories elucidating subclinical, chronic inflammatory
process in obesity, relatively less is known about possible
bacterial infection in the initiation of this process and in
modulation of its course. Does intracellular bacteria Chlamydia
pneumonia, associated with the progression of atheromatosis
which has been considered recently as a vascular inflammatory
disease, might be a factor initiating the cytokine cascade in obesity?
This bacterium may infect and live in number of the host
cells (including circulating monocytes, tissue macrophages, or
endothelial cells). If human immune system is unable to eliminate Chlamydia pneumoniae, the inflammation progresses to
a self-supporting chronic process, in which are essentially involved
macrophages infiltrating fat tissue, increased synthesis
of the pro-inflammatory cytokines, and C-reactive protein in adipose cells as a reaction of the body for prolonged antigen
stimulation.
Abstract
Obesity is associated with a mild and chronic inflammatory process.
There is increasing evidence that in obesity the adipocytes
secrete numerous bioactive substances, such as CRP,
IL-6, TNF-α, leptin and adiponectin. Thus, adipose tissue actively
contributes in the development of inflammatory response.
Among many theories elucidating subclinical, chronic inflammatory
process in obesity, relatively less is known about possible
bacterial infection in the initiation of this process and in
modulation of its course. Does intracellular bacteria Chlamydia
pneumonia, associated with the progression of atheromatosis
which has been considered recently as a vascular inflammatory
disease, might be a factor initiating the cytokine cascade in obesity?
This bacterium may infect and live in number of the host
cells (including circulating monocytes, tissue macrophages, or
endothelial cells). If human immune system is unable to eliminate Chlamydia pneumoniae, the inflammation progresses to
a self-supporting chronic process, in which are essentially involved
macrophages infiltrating fat tissue, increased synthesis
of the pro-inflammatory cytokines, and C-reactive protein in adipose cells as a reaction of the body for prolonged antigen
stimulation.